Promote Scientific Collaboration
Access to Unique Applications and Tools
HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website is currently a joint development effort by CHDI and UCLA, through the laboratory of Dr. Giovanni Coppola. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Latest news and publications from around the HD Ecosystem
- The third dimension: using minibrains to understand brain development changes in HD
- Could molecular handcuffs lower the protein that causes Huntington's disease?
- Exciting new Huntingtin lowering tool described
- Details emerge of first Huntington’s disease gene therapy clinical trial
- Fresh Updates from First Huntingtin Lowering Study Publication
- Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease.
- The Ripple Effect: A Qualitative Overview of Challenges When Growing Up in Families Affected by Huntington's Disease.
- Imaging mass spectrometry allows for neuroanatomic-specific detection of gangliosides in the healthy and diseased brain.
- Endocannabinoid receptors in the CNS: potential drug targets for the prevention and treatment of neurologic and psychiatric disorders.
- Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease.
- Wave Life Sciences (NASDAQ:WVE) Lowered to “Hold” at Zacks Investment Research
- IXICO to present scientific poster on enhancing imaging analysis accuracy <b>for Huntington's Disease</b>
- Latest Trends In Neuroprotective Products Market : Explore Most Recent Market Information With ...
- As FBI Tackles Chinese Espionage, Some Fear A New Red Scare
- Danvers clipped by Port in Gieras tourney